A Research Called CREDIT Studies How Safe the Study Treatment Radium-223 is and How Well it Works in Chinese Men With Advanced Prostate Cancer That Has Spread to the Bones and Does Not Respond to Treatments for Lowering Testosterone Levels
Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Bayer
Age
Any age
Sex
MALE
Healthy volunteers
Not accepted
You may be eligible if
Male patient
Histologically or cytologically confirmed castration resistant adenocarcinoma of the prostate with bone metastases
No visceral metastases
Decision to initiate treatment with Radium-223 was made independently prior to patient enrollment in the study as per investigator's routine treatment practice
Signed informed consent
You may not be if
Patients previously treated with Radium-223 for any reason
Patients currently treated in any other clinical trials including other Radium-223 studies
Patients are planned for the systemic concomitant use of other radiopharmaceuticals for treatment of prostate cancer or for other use
Participation in an investigational program with interventions outside of routine clinical practice
Patients previously treated with Docetaxel
Patients under treatment with Abiraterone Acetate and the Corticosteroids Prednisone or Prednisolone
Clareo Health | A Research Called CREDIT Studies How Safe the Study Treatment Radium-223 is and How Well it Works in Chinese Men With Advanced Prostate Cancer That Has Spread to the Bones and Does Not Respond to Treatments for Lowering Testosterone Levels
